imho most of the screening programs will be government directed and driven. the estimates for costs / deaths of colorectal cancer treatment - for Aus alone comes in at just over $8.5 billion (say 17 yr period) not including loss of life intangibles. I query whether marketing spend will be in issue. for example the cervical cancer screening program simply tells the GP's what process to use (recently changed from Pap smear program to a DNA cytology based program) this has no marketing it was simply government directive because it was superior. I anticipate agreements with govt as national screening program partners as opposed to driven by marketing spend
- Forums
- ASX - By Stock
- Ann: CE Mark Granted for ColoSTAT
imho most of the screening programs will be government directed...
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RHY (ASX) to my watchlist
|
|||||
Last
5.7¢ |
Change
-0.003(5.00%) |
Mkt cap ! $13.92M |
Open | High | Low | Value | Volume |
6.0¢ | 6.0¢ | 5.6¢ | $9.523K | 163.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 11967 | 5.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.0¢ | 12779 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 11967 | 0.057 |
2 | 26855 | 0.056 |
1 | 54545 | 0.055 |
1 | 68500 | 0.051 |
1 | 59995 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.060 | 12779 | 2 |
0.061 | 70899 | 1 |
0.062 | 144742 | 1 |
0.063 | 34 | 1 |
0.065 | 9750 | 1 |
Last trade - 12.33pm 10/07/2024 (20 minute delay) ? |
Featured News
RHY (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online